IMMUNO-PATOGENETIC CHANGES IF THE RESPIRATORY SYSTEM IS DAMAGED IN PATIENTS WITH RHEUMATOID ARTHRITIS

Authors

  • ABDUAZIZOVA Nargiza Khakimzhanovna
  • MUKHAMMADIYEVA Sevara Murodullaevna
  • PULATOV Khabibulla Khairullaevich
  • SHARAPOV Zafar Abdunaemovich
  • ZHAKSYMURATOVA Khurliman Tatlymuratovna

Keywords:

rheumatoid arthritis, respiratory system, cytokines, treatment

Abstract

This article is devoted to the study of immunological disorders of the respiratory system in patients with rheumatoid arthritis. The results of the study showed that immunological changes in the defeat of the respiratory system in patients with rheumatoid arthritis are more pronounced revealed by the seropositive course of the disease. This shows that the disease is accompanied by a significant increase in the number of pro-inflammatory cytokines, including ТNF-α and IL-6 causing destruction of the joints and damage to the respiratory system.

References

Муравьев Ю.В. Внесуставные проявления ревматоидного артрита. Научно-практическая ревматология 2018;56(3):356-62 [Muravyev YuV. Extra-articularmanifestations of rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya =Rheumatology Science and Practice. 2018;56(3):356-62 (In Russ.)].

Бестаев ДВ, Каратеев ДЕ, Насонов ЕЛ. Системные проявления ревматоид-ного артрита. Научно-практическая ревматология 2013;51(1):76-80 [BestaevDV, Karateev DE, Nasonov EL. Systemic manifestations of rheumatoid arthritis.Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice.2013;51(1):76-80 (In Russ.)].

Тареев Е.М. Висцеральные поражения при системных васкулитах и ревма-тоидном артрите. Советская медицина 1956;(5):10-8 [Tareev EM. Viscerallesions in systemic vasculitis and rheumatoid arthritis. Sovetskaya Meditsina1956;(5):10-8 (In Russ.)].

Каратеев Д.Е., Лучихина Е.Л. Современное состояние проблемы раннего артрита. Науч- практич ревматолог 2010;4 (Прил. 2):27-31

Насонов Е.Л. (ред.). Российские клинические рекомендации. Ревматология.Москва: ГЭОТАР-Медиа; 2017. 464 с. [Nasonov EL, editor. Rossiyskie klinic-heskie rekomendatsii. Revmatologiya (Russian clinical guidelines. Rheumatology).Moscow: GEOTAR-Media; 2017:464 p. (In Russ.)].

Елисеев М.С., Желябина О.В., Чикина М.Н. и др. Влияние терапии на субклинический атеросклероз сонных артерий у пациентов с болезнью депонирования кристаллов пирофосфатов кальция и остеоартритом (пилотное исследование). Научно-практическая ревматология журнал // – 2021. –Том:59 –№6. –С.708-714.

Насонов Е. Л., Рыбакова В. В., Авдеева А. С., Дибров Д. А. Отдаленные результаты интенсивной терапии раннего ревматоидного артрита в дебюте заболевания (по данным Российского регистра ОРЕЛ). Научно-практическая ревматология журнал // – 2021. – Том:59 –№3. –С. 269-274.

Nargiza Abduazizova, Sevara Mukhammadieva, Elnora Djurayeva,Gulnoza Rakhmatullaeva LIPID PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS ON THEBACKGROUND OF BASIC TREATMENT International Journal of Early Childhood Special Education (INT-JECSE)DOI: 10.9756/INT-JECSE/V14I1.382 ISSN: 1308-5581 Vol 14, Issue 01 2022 PP:3189-3191

Ilxomova K. A., Abduazizova N. Kh., Kasimova M. B., Agzamova G. S. Оptimization of methods of basic treatment of early rheumatoid arthritis american journal of medicine and medical sciences 2021, 11(3): 165-169Doi: 10.5923/j.ajmms.20211103.01

Fragoulis GE, Nikiphorou E, Larsen J, et al. Methotrexate-associated pneumoni-tis and rheumatoid arthritis-interstitial lung disease: current concepts for the diag-nosis and treatment. Front Med 2019;6:238.

Wijsenbeek M, Kreuter M, Olson A, et al. Progressive fibrosing interstitial lungdiseases: Current practice in diagnosis and management. Curr Med Res Opin2019;35:2015–24.

Flaherty KR, Wells AU, Cottin V. Nintedanib in progressive fibrosing interstitiallung diseases. N Engl J Med 2019;381(18):1718-27.

Kapoor T, Bathon J. Renal Manifestations of Rheumatoid Arthritis. Rheum DisClin North Am 2018;44(4):571-84.

G is М, Carvalho А, Sousa Р et al. Renal involvement in rheumatoid arthritis: analysis of 53 renal biopsies. Port J Nephrol Hypert 2017;31(1):25-30.

Farrow SJ, Kingsley GH, Scott DL Interventions for foot disease in rheumatoid arthritis: a systematic review. Arthritis Rheum. 2005 Aug 15;53(4):593-602.

Mejjad O, Vittecoq O, Pouplin S, et al. Foot orthotics decrease pain but do not improve gait in rheumatoid arthritis patients. Joint Bone Spine. 2004 Nov;71(6):542-5.

Fransen M, Edmonds J. Off-the-shelf orthopedic footwear for people with rheumatoid arthritis. Arthritis Care Res. 1997 Aug;10(4):250-6.

Hodge MC, Bach TM, Carter GM Orthotic management of plantar pressure and pain in rheumatoid arthritis. Clin Biomech (Bristol, Avon). 1999 Oct;14(8):567-75.

Jackson L, Binning J, Potter J. Plantar pressures in rheumatoid arthritis using prefabricated metatarsal padding. J Am Podiatr Med Assoc. 2004 May-Jun;94(3):239-45.

Chalmers AC, Busby C, Goyert J, et al. Metatarsalgia and rheumatoid arthritis a randomized, single blind, sequential trial comparing 2 types of foot orthoses and supportive shoes. J Rheumatol. 2000Jul;27(7):1643-7.

Kavlak Y, Uygur F, Korkmaz C, et al. Outcome of orthoses intervention in the rheumatoid foot. Foot Ankle Int. 2003 Jun;24(6):494-9.

Cho NS, Hwang JH, Chang HJ, et al. Randomized controlled trial for clinical effects of varying types of insoles combined with specialized shoes in patients with rheumatoid arthritis of the foot. Clin Rehabil. 2009 Jun; 23(6):512-21.

Ризаев, Ж. А. Роль иммунной системы ротовой полости при инфицировании пациентов коронавирусом SARS-COV-2 / Ж. А. Ризаев, Э. А. Ризаев, А. С. Кубаев // Здоровье, демография, экология финно-угорских народов. – 2020. – № 3. – С. 67-69. – EDN GBYVTK.

Yusupov Mashrab, Rizaev Zhasur, Ziyadullaev Shuxrat. The value of cytokines in children with escherichiosis. Journal of Biomedicine and Practice. 2022, vol. 7, issue 4, pp.58-63

Fattayeva D. R., Rizayev J. A., Rakhimova D. A. IMPROVEMENT OF METHODS FOR CORRECTION OF CLINICAL AND IMMUNOLOGICAL DISORDERS IN COMORBID STATE OF CHRONIC GAYMORITIS AFTER COVID-19 //Art of Medicine. International Medical Scientific Journal. – 2021. – Т. 1. – №. 1.

Elmamatov, O., Raximov, N., Ziyadullaev, S., & Murodov, S. (2021). MOLECULAR MARKER IN THE PATIENTS WITH RECURRENT BLADDER CANCER. Збірник наукових праць SCIENTIA.

Ziyadullaev S. K. et al. MARKER TNFα-308G/A IN PATIENTS WITH RELATIVE BLADDER CANCER //Oriental renaissance: Innovative, educational, natural and social sciences. – 2021. – Т. 1. – №. 8. – С. 926-932.

Зиядуллаев Ш., Рахимов Н., Элмаматов О. Иммуноцитогенетические аспекты рака мочевого пузыря //Журнал вестник врача. – 2020. – Т. 1. – №. 4.

Published

2023-05-26